Logo
x

Search category

Subscribe Now

Commercialization rights

Alcon to Acquire Exclusive US Commercialization Rights to Novartis' Simbrinza

Alcon to Acquire Exclusive US Commercialization Rights to Novartis' Simbrinza

  • April 29, 2021
Encore Dermatology to Acquire US Commercialization Rights for Dr. Reddy's Three Dermatology Products

Encore Dermatology to Acquire US Commercialization Rights for Dr. Reddy's Three Dermatology Products

  • April 3, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.